novel
coronaviru
outbreak
global
health
concern
genet
sequenc
novel
coronaviru
risk
assess
time
guard
suggest
outbreak
like
caus
middl
east
respiratori
syndrom
mer
coronaviru
sever
acut
respiratori
syndrom
sar
coronaviru
howev
inform
appear
firstgener
case
point
sourc
time
seem
second
gener
perhap
third
gener
case
alreadi
report
incub
period
gener
appear
includ
health
worker
health
worker
infect
omin
find
emerg
infect
frontlin
health
worker
initi
risk
infect
examin
treat
patient
present
respiratori
infect
handwash
infect
prevent
control
measur
place
health
worker
great
risk
infect
becom
inadvert
carrier
patient
hospit
diseas
treatment
famili
member
commun
earli
sar
coronaviru
outbreak
frontlin
health
worker
becam
infect
amplifi
transmiss
patient
hospit
outbreak
occur
earli
evid
initi
mer
outbreak
suggest
health
worker
likewis
infect
infect
less
sever
patient
hospit
becam
infect
comorbid
diabet
chronic
respiratori
diseas
today
epidemiolog
sar
mer
virus
mostli
understood
true
current
outbreak
data
continu
freeli
share
use
provid
realtim
guidanc
articl
other
rapidli
dissemin
share
major
role
assur
global
collabor
occur
jan
total
case
laboratoryconfirm
infect
detect
china
die
remain
hospit
figur
lancet
chaolin
huang
colleagu
report
clinic
featur
first
patient
admit
design
hospit
wuhan
confirm
infect
jan
studi
find
provid
firsthand
data
sever
emerg
infect
symptom
result
infect
prodrom
phase
includ
fever
dri
cough
malais
nonspecif
unlik
human
coronaviru
infect
upper
respiratori
symptom
notabl
infrequ
intestin
present
observ
sar
also
appear
uncommon
although
two
six
case
report
chan
colleagu
diarrhoea
common
laboratori
find
admiss
hospit
includ
lymphopenia
bilater
groundglass
opac
consolid
chest
ct
scan
clinic
present
confound
earli
detect
infect
case
especi
background
ongo
influenza
circul
respiratori
virus
exposur
histori
huanan
seafood
wholesal
market
serv
import
clue
earli
stage
yet
valu
decreas
secondari
tertiari
case
appear
patient
cohort
develop
sever
dyspnoea
requir
admiss
intens
care
unit
six
die
henc
casefat
proport
cohort
approxim
overal
case
fatal
proport
appear
closer
tabl
howev
estim
treat
great
caution
patient
conclud
ill
ie
recov
die
true
number
infect
full
diseas
spectrum
unknown
importantli
emerg
viral
infect
outbreak
casefat
ratio
often
overestim
earli
stage
case
detect
highli
bias
toward
sever
case
data
spectrum
mild
asymptomat
infect
becom
avail
one
case
document
chan
colleagu
casefat
ratio
like
decreas
nevertheless
influenza
pandem
estim
casefat
ratio
less
enorm
impact
due
wide
spread
transmiss
room
complac
rna
viru
still
inher
featur
high
mutat
rate
although
like
coronavirus
mutat
rate
might
somewhat
lower
rna
virus
genomeencod
exonucleas
aspect
provid
possibl
newli
introduc
zoonot
viral
pathogen
adapt
becom
effici
transmit
person
person
possibl
becom
virul
infect
least
peopl
caus
death
intern
spread
sarscov
attribut
strong
transmiss
abil
specif
circumst
insuffici
prepared
implement
infect
control
practic
chines
public
health
scientif
capabl
greatli
transform
sinc
effici
system
readi
monitor
respond
infecti
diseas
outbreak
pneumonia
quickli
ad
notifi
communic
diseas
list
given
highest
prioriti
chines
health
author
increas
number
case
widen
geograph
spread
diseas
rais
grave
concern
futur
trajectori
outbreak
especi
chines
lunar
new
year
quickli
approach
normal
circumst
estim
billion
trip
would
made
spring
festiv
travel
rush
year
million
trip
happen
wuhan
viru
might
spread
place
festiv
period
caus
epidem
especi
acquir
abil
effici
transmit
person
person
consequ
outbreak
led
implement
extraordinari
public
health
measur
reduc
spread
viru
within
china
elsewher
although
recommend
intern
travel
restrict
far
local
govern
wuhan
announc
jan
suspens
public
transport
closur
airport
railway
station
highway
citi
prevent
diseas
transmiss
effort
travel
restrict
might
follow
activ
surveil
new
case
close
monitor
contact
implement
improv
detect
effici
frontlin
clinic
apart
local
centr
diseas
control
prevent
arm
valid
pointofcar
diagnost
kit
rapid
inform
disclosur
top
prioriti
diseas
control
prevent
daili
press
releas
system
establish
china
ensur
effect
effici
disclosur
epidem
inform
educ
campaign
launch
promot
precaut
travel
includ
frequent
handwash
cough
etiquett
use
person
protect
equip
eg
mask
visit
public
place
also
gener
public
motiv
report
fever
risk
factor
coronaviru
infect
includ
travel
histori
affect
area
close
contact
confirm
suspect
case
consid
substanti
number
patient
sar
mer
infect
healthcar
set
precaut
need
taken
prevent
nosocomi
spread
viru
unfortun
healthcar
worker
work
ward
confirm
infect
date
although
rout
transmiss
possibl
role
socal
superspread
remain
clarifi
epidemiolog
studi
need
done
assess
risk
factor
infect
healthcar
personnel
quantifi
potenti
subclin
asymptomat
infect
notabl
transmiss
sarscov
eventu
halt
public
health
measur
includ
elimin
nosocomi
infect
need
wari
current
outbreak
turn
sustain
epidem
even
pandem
avail
viru
genet
sequenc
initi
data
epidemiolog
clinic
consequ
infect
first
step
understand
threat
pose
pathogen
mani
import
question
remain
unansw
includ
origin
extent
durat
transmiss
human
abil
infect
anim
host
spectrum
pathogenesi
human
infect
characteris
viral
isol
success
gener
human
infect
key
updat
diagnost
assess
viral
evolut
beyond
support
care
specif
coronaviru
antivir
vaccin
proven
efficaci
human
exist
although
clinic
trial
ongo
merscov
one
control
trial
ritonavirboost
lopinavir
monotherapi
launch
futur
anim
model
clinic
studi
focu
assess
effect
safeti
promis
antivir
drug
monoclon
polyclon
neutralis
anti
bodi
product
therapeut
direct
immunopatholog
host
respons
awar
challeng
concern
brought
commun
everi
effort
given
understand
control
diseas
time
act
fgh
report
person
fee
univers
alabama
antivir
drug
discoveri
develop
consortium
noncompens
consult
gilead
scienc
regeneron
sab
biotherapeut
investig
therapeut
coronaviru
infect
author
declar
compet
interest
novel
coronaviru
outbreak
major
challeng
clinician
clinic
cours
patient
remain
fulli
characteris
littl
data
avail
describ
diseas
pathogenesi
pharmacolog
therapi
proven
efficaci
yet
exist
corticosteroid
wide
use
outbreak
sever
acut
respiratori
syndrom
sar
cov
middl
east
respiratori
syndrom
mer
cov
use
patient
addit
therapeut
howev
current
interim
guidanc
clinic
manag
sever
acut
respiratori
infect
novel
coronaviru
infect
suspect
releas
jan
advis
use
corticosteroid
unless
indic
clinic
evid
support
corticosteroid
treatment
lung
injuri
